Skip to main content
Fig. 7 | BMC Pulmonary Medicine

Fig. 7

From: ANK2 as a novel predictive biomarker for immune checkpoint inhibitors and its correlation with antitumor immunity in lung adenocarcinoma

Fig. 7

Association between ANK2 expression and immune-related signatures in LUAD A: Differences in immune cell infiltration between high- and low-ANK2 expression LUAD. B, C: Association of ANK2 expression with immuno-stimulators (B) and immuno-inhibitors (C) in LUAD. D: Correlation of ANK2 expression with MHC molecules expression in LUAD. E, F: Correlation of ANK2 expression with the expression of chemokines (E) and their receptors (F) in LUAD (*P < 0.05, **P < 0.01, ***P < 0.001)

Back to article page

BMC Pulmonary Medicine

ISSN: 1471-2466

Contact us